ctrl K

Price Alert

Novo Integrated Sciences ... (NVOS)

OTC: NVOS · Real-Time Price · USD

0.00

-0.00 (-100.00%)

At close: Apr 03, 2025, 10:15 AM

Novo Integrated Sciences Balance Sheet Statement

Financials in USD. Fiscal year is September - August.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021
Cash & Equivalents	844.58K	416.32K	2.18M	8.29M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	692.74K
Other Long-Term Assets	n/a	n/a	n/a	692.74K
Receivables	3.15M	1.47M	2.1M	2.28M
Inventory	1M	1.11M	879.03K	339.38K
Other Current Assets	417.28K	346.17K	571.34K	n/a
Total Current Assets	5.41M	4.39M	5.73M	11.13M
Property-Plant & Equipment	6.8M	7.37M	8.47M	8.61M
Goodwill & Intangibles	19.92M	23.8M	26.67M	41.52M
Total Long-Term Assets	26.73M	31.17M	35.14M	50.82M
Total Assets	32.14M	35.56M	40.87M	61.96M
Account Payables	3.24M	3.51M	1.8M	1.45M
Deferred Revenue	n/a	35.43K	36.89K	38.63K
Short-Term Debt	3.16M	2.29M	9.1M	4.96M
Other Current Liabilities	8.19M	1.41M	2.35M	1.22M
Total Current Liabilities	14.58M	7.9M	14.07M	8.46M
Long-Term Debt	1.55M	65.04K	1.11M	6.12M
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	2.95M	3.16M	4.75M	9.69M
Total Liabilities	17.53M	11.06M	18.83M	18.15M
Total Debt	4.71M	4.47M	13M	13.71M
Book Value	n/a	n/a	n/a	n/a
Book Value Per Share	n/a	n/a	n/a	n/a
Common Stock	19.05K	15.76K	3.12K	26.61K
Retained Earnings	-83.2M	-67.03M	-53.82M	-20.97M
Comprehensive Income	n/a	-357.38K	560.84K	991.08K
Shareholders Equity	14.89M	24.82M	22.31M	43.86M
Total Investments	n/a	n/a	n/a	692.74K